The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Open accessAbstract
Detection of circulating tumor DNA in patients with resected stage II colon cancer provides evidence of residual disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a growing body of data demonstrating numerous clinical applications for ctDNA in adults with solid tumors, ranging from prognostication and evaluation of minimal residual disease (MRD) to detection of targetable alterations.7–12”
From Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study (2026) · cites this paper as [10]
In the citing paper
“A salient example of the well-established relationship between ctDNA burden and disease status in adult solid tumors is the use of ctDNA for MRD detection and monitoring for recurrence in colorectal cancers.10–12”
From Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study (2026) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citationTime‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Self-citationCirculating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746
Self-citationRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Self-citationSargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Research works printed but not linked: 1
- S. Edge D. R. Byrd C. C. Compton A. G. Fritz F. L. Greene A. Trotti AJCC Cancer Staging Manual (Springer New York 2010) 648 pp.
Cited by
Sorted by citations
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00762-6 · Cited by 2,519
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Abbosh, C., Birkbak, N. J., Wilson, G. A., Jamal‐Hanjani, M., Constantin, T. P., Salari, R., Quesne, J. P. C. L., Moore, D. A., Veeriah, S., Rosenthal, R., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,900
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Argilés, G., Tabernero, J., Labianca, R., Hochhauser, D., Salazar, R., Iveson, T., Laurent-Puig, P., Quirke, P., Yoshino, T., Taieb, J., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.022 · Cited by 1,375
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0187-3 · Cited by 1,110
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Tie, J., Cohen, J. D., Lahouel, K., Lo, S. N., Wang, Y., Kosmider, S., Wong, R., Shapiro, J., Lee, M., Harris, S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200075 · Cited by 1,091
Self-citationChaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., Khodadoust, M. S., Esfahani, M. S., Liu, C. L., Zhou, L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0716 · Cited by 1,105
Enhanced detection of circulating tumor DNA by fragment size analysis
Mouliere, F. C., Chandrananda, D., Piskorz, A., Moore, E. K., Morris, J., Ahlborn, L. B., Mair, R. J., Goranova, T., Marass, F., Heider, K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4921 · Cited by 1,095
Reinert, T., Henriksen, T. V., Christensen, E., Sharma, S., Salari, R., Sethi, H., Knudsen, M., Nordentoft, I., Wu, H.-T., Tin, A. S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0528 · Cited by 1,011
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Dienstmann, R., Vermeulen, L., Guinney, J., Kopetz, S., Tejpar, S., & Tabernero, J. M. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.126 · Cited by 1,075
Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., Lindeman, N., Lockwood, C. M., Rai, A. J., Schilsky, R. L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8671 · Cited by 959
Liquid Biopsy: From Discovery to Clinical Application
Alix‐Panabières, C., & Pantel, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1311 · Cited by 1,006
Application of Cell-free DNA Analysis to Cancer Treatment
Corcoran, R. B., & Chabner, B. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706174 · Cited by 980
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Lone, S. N., Nisar, S., Masoodi, T., Singh, M. K., Rizwan, A., Hashem, S., El-Rifai, W. M., Bedognetti, D., Batra, S. K., Haris, M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01543-7 · Cited by 866
Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
Chan, K. C. A., Woo, J. K. S., King, A. D., Zee, B. C.-Y., Lam, W. K., Chan, S. L., Chu, S. W. I., Mak, C., Tse, I. O. L., Leung, S. Y. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701717 · Cited by 792
Pascual, J., Attard, G., Bidard, F.-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., Italiano, A., Lindberg, J., Merker, J. D., Montagut, C., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.520 · Cited by 783
Self-citationStrategies for Colorectal Cancer Screening
Ladabaum, U., Dominitz, J. A., Kahi, C., & Schoen, R. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.043 · Cited by 696
Rolfo, C., Mack, P., Scagliotti, G. V., Aggarwal, C., Arcila, M. E., Barlesi, F., Bivona, T., Diehn, M., Dive, C., Dziadziuszko, R., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.06.017 · Cited by 683
Tie, J., Cohen, J. D., Wang, Y., Christie, M., Simons, K., Lee, M., Wong, R., Kosmider, S., Ananda, S., McKendrick, J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3616 · Cited by 668
Self-citationFeasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Lennon, A. M., Buchanan, A. H., Kinde, I., Warren, A., Honushefsky, A. M., Cohain, A. T., Ledbetter, D. H., Sanfilippo, F. P., Sheridan, K. M., Rosica, D., et al. (2020) · Science · doi:10.1126/science.abb9601 · Cited by 665
Self-citationctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Powles, T. B., Assaf, Z. J. F., Davarpanah, N. N., Banchereau, R., Szabados, B. E., Yuen, K. C. Y., Grivas, P. D., Hussain, M., Oudard, S. M., Gschwend, J. E., et al. (2021) · Nature · doi:10.1038/s41586-021-03642-9 · Cited by 679
The emerging clinical relevance of genomics in cancer medicine
Berger, M. F., & Mardis, E. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0002-6 · Cited by 640
Life and death of circulating cell-free DNA
Kustanovich, A., Schwartz, R., Peretz, T., & Grinshpun, A. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1598759 · Cited by 643
Burstein, H. J., Krilov, L., Aragon‐Ching, J. B., Baxter, N. N., Chiorean, E. G., Chow, W. A., Groot, J. F. D., Devine, S. M., DuBois, S. G., El‐Deiry, W. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.5292 · Cited by 603
Circulating tumor DNA and liquid biopsy in oncology
Cescon, D. W., Bratman, S. V., Chan, S. M., & Siu, L. L. (2020) · Nature Cancer · doi:10.1038/s43018-020-0043-5 · Cited by 600
The emerging role of cell-free DNA as a molecular marker for cancer management
Bronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2019.100087 · Cited by 566
Christensen, E., Birkenkamp‐Demtröder, K., Sethi, H., Shchegrova, S., Salari, R., Nordentoft, I., Wu, H.-T., Knudsen, M., Lamy, P., Lindskrog, S. V., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02052 · Cited by 560
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
Keller, L., & Pantel, K. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0180-2 · Cited by 560
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
Salk, J. J., Schmitt, M. W., & Loeb, L. A. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.117 · Cited by 551
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
Rubis, G. D., Krishnan, S. R., & Bebawy, M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.006 · Cited by 533
Quantitative evidence for early metastatic seeding in colorectal cancer
Hu, Z., Ding, J., Ma, Z., Sun, R., Seoane, J. A., Shaffer, J. S., Suarez, C. J., Berghoff, A. S., Cremolini, C., Falcone, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0423-x · Cited by 480
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., Lovejoy, A. F., Chabon, J. J., Klass, D. M., Liu, C. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8545 · Cited by 495
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Eng, C., Yoshino, T., Ruíz‐García, E., Mostafa, N., Cann, C., O’Brian, B., Benny, A., Perez, R. O., & Cremolini, C. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00360-x · Cited by 508
Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
Abbosh, C., Birkbak, N. J., & Swanton, C. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0058-3 · Cited by 451
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Palmirotta, R., Lovero, D., Cafforio, P., Felici, C., Mannavola, F., Pellè, E., Quaresmini, D., Tucci, M., & Silvestris, F. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918794630 · Cited by 448
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
García-Murillas, I., Chopra, N., Comino‐Méndez, I., Beaney, M., Tovey, H., Cutts, R. J., Swift, C., Kriplani, D., Afentakis, M., Hrebien, S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1838 · Cited by 420
Vogel, J. D., Felder, S. I., Bhama, A. R., Hawkins, A. T., Langenfeld, S. J., Shaffer, V. O., Thorsen, A. J., Weiser, M. R., Chang, G. J., Lightner, A. L., et al. (2021) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002323 · Cited by 458
Parikh, A. R., Seventer, E. E. V., Siravegna, G., Hartwig, A. V., Jaimovich, A., He, Y., Kanter, K. N., Fish, M. G., Fosbenner, K. D., Miao, B., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0410 · Cited by 400
Tie, J., Cohen, J. D., Wang, Y., Li, L., Christie, M., Simons, K., Elsaleh, H., Kosmider, S., Wong, R., Yip, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315852 · Cited by 385
Self-citationKurtz, D. M., Soo, J., Keh, L. C. T., Alig, S., Chabon, J. J., Sworder, B. J., Schultz, A., Jin, M. C., Scherer, F., Garofalo, A., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00981-w · Cited by 383
Dasari, A. N., Morris, V. K., Allegra, C. J., Atreya, C. E., Benson, A. B., Boland, P. M., Chung, K., Copur, M. S., Corcoran, R. B., Deming, D. A., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0392-0 · Cited by 386
Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection
Aravanis, A. M., Lee, M., & Klausner, R. D. (2017) · Cell · doi:10.1016/j.cell.2017.01.030 · Cited by 375
Moding, E. J., Liu, Y., Nabet, B. Y., Chabon, J. J., Chaudhuri, A. A., Hui, A. B., Bonilla, R. F., Ko, R. B., Yoo, C. H., Gojenola, L., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0011-0 · Cited by 366
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Bernard, V., Kim, D. U., Lucas, F. A. S., Castillo, J., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J. H., Semaan, A., Guerrero, P. A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.022 · Cited by 364
How liquid biopsies can change clinical practice in oncology
Siravegna, G., Mussolin, B., Venesio, T., Marsoni, S., Seoane, J., Dive, C., Papadopoulos, N., Kopetz, S., Corcoran, R. B., Siu, L. L., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz227 · Cited by 376
Self-citationGale, D. G., Heider, K., Ruiz-Valdepeñas, A., Hackinger, S., Perry, M., Marsico, G., Rundell, V., Wulff, J., Sharma, G., Knock, H., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.02.007 · Cited by 352
van der Pol, Y., & Mouliere, F. C. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.09.003 · Cited by 333
Song, P., Wu, L. R., Yan, Y. H., Zhang, J. X., Chu, T., Kwong, L. N., Patel, A. A., & Zhang, D. Y. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00837-3 · Cited by 334
Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
Moding, E. J., Nabet, B. Y., Alizadeh, A. A., & Diehn, M. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0634 · Cited by 325
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
Luo, H., Wei, W., Ye, Z., Zheng, J., & Xu, R. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.12.011 · Cited by 322
Klaver, C. E. L., Wisselink, D. D., Punt, C. J. A., Snæbjörnsson, P., Crezee, J., Aalbers, A. G. J., Brandt, A., Bremers, A. J. A., Burger, J. W. A., Fabry, H. F. J., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30239-0 · Cited by 324
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Schøler, L. V., Reinert, T., Ørntoft, M. W., Kassentoft, C. G., Árnadóttir, S. S., Vang, S., Nordentoft, I., Knudsen, M., Lamy, P., Andreasen, D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0510 · Cited by 309
McDonald, B. R., Contente‐Cuomo, T., Sammut, S., Odenheimer-Bergman, A., Ernst, B. J., Perdigones, N., Chin, S., Farooq, M., Mejia, R., Cronin, P. A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7392 · Cited by 307
Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
Malla, M., Loree, J. M., Kasi, P. M., & Parikh, A. R. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02615 · Cited by 309
Tarazona, N., Gimeno-Valiente, F., Gambardella, V., Zúñiga, S., Rentero-Garrido, P., Huerta, M., Roselló, S., Martínez‐Ciarpaglini, C., Carbonell‐Asins, J. A., Carrasco, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz390 · Cited by 288
Liquid biopsies: Potential and challenges
Heidrich, I., Ačkar, L., Mohammadi, P. M., & Pantel, K. (2020) · International Journal of Cancer · doi:10.1002/ijc.33217 · Cited by 284
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Deveson, I. W., Gong, B., Lai, K., LoCoco, J. S., Richmond, T., Schageman, J. J., Zhang, Z., Novoradovskaya, N., Willey, J. C., Jones, W. D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00857-z · Cited by 288
Circulating biomarkers for early detection and clinical management of colorectal cancer
Marcuello, M., Vymetalkova, V. P., Neves, R. P., Durán-Sanchón, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., García‐Barberán, V., Fijneman, R. J. A., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.002 · Cited by 283
Azad, T. D., Chaudhuri, A. A., Fang, P., Qiao, Y., Esfahani, M. S., Chabon, J. J., Hamilton, E. G., Yang, Y. D., Lovejoy, A., Newman, A. M., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.10.039 · Cited by 275
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Fiala, C., & Diamandis, E. P. (2018) · BMC Medicine · doi:10.1186/s12916-018-1157-9 · Cited by 284
Henriksen, T. V., Tarazona, N., Frydendahl, A., Reinert, T., Gimeno-Valiente, F., Carbonell-Asins, J. A., Sharma, S., Renner, D., Hafez, D., Roda, D., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2404 · Cited by 273
Xia, L., Mei, J., Kang, R., Deng, S., Chen, Y., Yang, Y., Feng, G., Deng, Y., Gan, F., Lin, Y., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3044 · Cited by 269
Self-citationDeterminants of metastatic competency in colorectal cancer
Tauriello, D. V. F., Calon, A., Lonardo, E., & Batlle, E. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12018 · Cited by 262
Beckmann, J. S., & Lew, D. (2016) · Genome Medicine · doi:10.1186/s13073-016-0388-7 · Cited by 267
Postel, M., Roosen, A., Laurent‐Puig, P., Taly, V., & Renault, S. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1400384 · Cited by 255
Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology
Bartolomucci, A., de Nóbrega, M., Ferrier, S. T., Dickinson, K., Kaorey, N., Nadeau, A., Castillo, A., & Burnier, J. V. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00876-y · Cited by 301
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Dudley, J. C., Schroers‐Martin, J. G., Lazzareschi, D. V., Shi, W. T., Chen, S., Esfahani, M. S., Trivedi, D. R., Chabon, J. J., Chaudhuri, A. A., Stehr, H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0825 · Cited by 255
Cancer evolution: Darwin and beyond
Vendramin, R., Litchfield, K., & Swanton, C. (2021) · The EMBO Journal · doi:10.15252/embj.2021108389 · Cited by 269
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Leal, A., van Grieken, N. C. T., Palsgrove, D. N., Phallen, J. A., Medina, J. E., Hruban, C., Broeckaert, M. A. M., Anagnostou, V., Adleff, V., Bruhm, D. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14310-3 · Cited by 245
Targeted therapies for renal cell carcinoma
Posadas, E. M., Limvorasak, S., & Figlin, R. A. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.82 · Cited by 246
Torkamani, A., Andersen, K. G., Steinhubl, S. R., & Topol, E. J. (2017) · Cell · doi:10.1016/j.cell.2017.08.007 · Cited by 253
S3-Leitlinie – Kolorektales Karzinom
Schmiegel, W., Buchberger, B., Follmann, M., Graeven, U., Heinemann, V., Langer, T. G., Nothacker, M., Porschen, R., Rödel, C. M., Rösch, T., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-121106 · Cited by 247
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
Kurtz, D. M., Esfahani, M. S., Scherer, F., Soo, J., Jin, M. C., Liu, C. L., Newman, A. M., Dührsen, U., Hüttmann, A., Casasnovas, O., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.011 · Cited by 240
Barault, L., Amatu, A., Siravegna, G., Ponzetti, A., Morán, S., Cassingena, A., Mussolin, B., Falcomatà, C., Binder, A. M., Cristiano, C., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313372 · Cited by 234
Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
Maron, S. B., Chase, L. M., Lomnicki, S., Kochanny, S. E., Moore, K. L., Joshi, S. S., Landron, S., Johnson, J., Kiedrowski, L. A., Nagy, R. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1704 · Cited by 232
Wang, Y., Li, L., Cohen, J. D., Kinde, I., Ptak, J., Popoli, M., Schaefer, J., Silliman, N., Dobbyn, L., Tie, J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0512 · Cited by 230
Self-citationMerker, J. D., Oxnard, G. R., Compton, C. C., Diehn, M., Hurley, P. A., Lazar, A. J., Lindeman, N. I., Lockwood, C. M., Rai, A. J., Schilsky, R. L., et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0901-sa · Cited by 227
Circulating tumor cells: clinical validity and utility
Cabel, L., Proudhon, C., Gortais, H., Loirat, D., Coussy, F., Pierga, J., & Bidard, F. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1105-2 · Cited by 223
BRCA1/2 testing: therapeutic implications for breast cancer management
Tung, N., & Garber, J. E. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0127-5 · Cited by 228
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
Batool, S. M., Yekula, A., Khanna, P., Hsia, T., Gamblin, A. S., Ekanayake, E., Escobedo, A. K., You, D. G., Castro, C. M., Im, H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101198 · Cited by 221
Self-citationGraczyk, E. L., Resnik, L. J., Schiefer, M. A., Schmitt, M. S., & Tyler, D. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-26952-x · Cited by 214
Early colorectal cancer: diagnosis, treatment and survivorship care
Buccafusca, G., Proserpio, I., Tralongo, A. C., Giuliano, S. R., & Tralongo, P. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.023 · Cited by 216
Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
Groot, V. P., Mosier, S. L., Javed, A. A., Teinor, J. A., Gemenetzis, G., Ding, D., Haley, L. M., Yu, J., Burkhart, R. A., Hasanain, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0197 · Cited by 220
A mathematical model of ctDNA shedding predicts tumor detection size
Avanzini, S., Kurtz, D. M., Chabon, J. J., Moding, E. J., Hori, S. S., Gambhir, S. S., Alizadeh, A. A., Diehn, M., & Reiter, J. G. (2020) · Science Advances · doi:10.1126/sciadv.abc4308 · Cited by 217
ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
Neumann, M. H., Bender, S., Krahn, T., & Schlange, T. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.05.002 · Cited by 216
Nong, J., Gong, Y., Guan, Y., Yi, X., Yi, Y., Chang, L., Yang, L., Lv, J., Guo, Z., Jia, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05327-w · Cited by 202
Yang, J., Gong, Y., Lam, V. K. L., Shi, Y., Guan, Y., Zhang, Y., Ji, L., Chen, Y., Zhao, Y., Qian, F., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2531-z · Cited by 208
Pellini, B., & Chaudhuri, A. A. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01929 · Cited by 203
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
Cabel, L., Proudhon, C., Romano, E., Girard, N., Lantz, O. J., Stern, M., Pierga, J., & Bidard, F. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0074-3 · Cited by 197
Applications of liquid biopsies for cancer
Mattox, A. K., Bettegowda, C., Zhou, S., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1984 · Cited by 196
Self-citationPanditharatna, E., Kilburn, L. B., Aboian, M., Kambhampati, M., Gordish‐Dressman, H., Magge, S. N., Gupta, N. M., Myseros, J. S., Hwang, E. I., Kline, C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1345 · Cited by 197
ctDNA monitoring using patient-specific sequencing and integration of variant reads
Wan, J. C. M., Heider, K., Gale, D. G., Murphy, S., Fisher, E., Mouliere, F. C., Ruiz-Valdepeñas, A., Santonja, Á., Morris, J., Chandrananda, D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz8084 · Cited by 204
Tumor Evolution as a Therapeutic Target
Amirouchene-Angelozzi, N., Swanton, C., & Bardelli, A. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0343 · Cited by 197
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer
Parsons, H. A., Rhoades, J., Reed, S. C., Gydush, G., Ram, P., Exman, P., Xiong, K., Lo, C. C., Li, T., Fleharty, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3005 · Cited by 194
Sanz‐García, E., Stutheit-Zhao, E. Y., Bratman, S. V., & Siu, L. L. (2022) · Science Advances · doi:10.1126/sciadv.abi8618 · Cited by 196
Chen, G., Peng, J., Xiao, Q., Wu, H., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01089-z · Cited by 199
Self-citationPrediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
Tan, L., Sandhu, S. K., Lee, R. J., Li, J., Callahan, J., Ftouni, S., Dhomen, N. S., Middlehurst, P., Wallace, A. J., Raleigh, J., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz048 · Cited by 196
Self-citationClonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
Chan, H. T., Chin, Y. M., Nakamura, Y., & Low, S. (2020) · Cancers · doi:10.3390/cancers12082277 · Cited by 192
Metadata
- Authors
- Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., Kosmider, S., Skinner, I., Wong, R., Steel, M., Tran, B., Desai, J., Jones, I., Haydon, A., Hayes, T., Price, T. J., Strausberg, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., & Gibbs, P.
- Affiliations
- The University of Melbourne (AU)
- Howard Hughes Medical Institute (US)
- Johns Hopkins University (US)
- PapGene (United States) (US)
- The Royal Melbourne Hospital (AU)
- Western Health (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Eastern Health (AU)
- The Alfred Hospital (AU)
- Department of Medical Oncology, Warrnambool Hospital, Warrnambool, Victoria 3280, Australia.
- Department of Medical Oncology, Queen Elizabeth Hospital and University of Adelaide, Adelaide, South Australia 3174, Australia.
- Ludwig Cancer Research (US)
- Corresponding author
- Tie, Jeanne
- Wang, Yuxuan
- Vogelstein, Bert
- Gibbs, Peter
- ORCID
- Tie, Jeanne
- Wang, Yuxuan
- Tomasetti, Cristian
- Li, Lu
- Springer, Simeon
- Silliman, Natalie
- Tacey, Mark
- Wong, Hui-Li
- Christie, Michael
- Kosmider, Suzanne
- Skinner, Iain
- Wong, Rachel
- Steel, Malcolm
- Tran, Ben
- Desai, Jayesh
- Jones, Ian
- Haydon, Andrew
- Hayes, Theresa
- Diaz, Luis A.
- Papadopoulos, Nickolas
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Gibbs, Peter
- Venue
- Science Translational Medicine
- Published
- 2016-07-06
- Volume
- 8
- Issue
- 346
- Pages
- 346ra92-346ra92
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC5346159
- OpenAlex
- W2460179076
- Cited by
- 1,492
- References
- 43
- Citations by year
- 2026: 119 · 2025: 131 · 2024: 130 · 2023: 181 · 2022: 173 · 2021: 197 · 2020: 173 · 2019: 146 · 2018: 134 · 2017: 90 · 2016: 14
- FWCI
- 53.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Virginia and D.K. Ludwig Fund for Cancer Research
- Conrad N. Hilton Foundation
- Sol Goldman Sequencing Facility at Johns Hopkins
- NIH (CA57345, R37-CA43460, U01-CA152753, P30-CA006973)
- Victorian Cancer Agency
- Victorian Cancer Agency Clinical Research Fellowship
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- circulating tumor DNA, stage II colon cancer, minimal residual disease, tumor recurrence prediction, adjuvant chemotherapy, liquid biopsy, recurrence-free survival, plasma biomarkers, resected colon cancer
- MeSH terms
- Circulating Tumor DNA, Colonic Neoplasms, Humans, Neoplasm Recurrence, Local, Neoplasm Staging, Prospective Studies, Proportional Hazards Models, Neoplasm, Residual, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
